Kyndryl has partnered with Dr. Reddy’s Laboratories to revamp the company’s IT operations across the board — from manufacturing facilities and data centers to cloud infrastructure and office networks. The goal is to build a more efficient, proactive, and automated IT environment that can keep up with the scale and complexity of the pharmaceutical giant’s operations.
At the core of this transformation is Kyndryl Bridge, an AI-powered integration platform designed to give organizations deeper visibility and control over hybrid IT environments. For Dr. Reddy’s, this means automated monitoring, predictive analytics to flag potential system failures before they occur, and built-in auto-remediation features that can resolve common issues without human intervention.
Beyond just automation, Kyndryl is introducing a Zero Touch IT Operations model, aimed at minimizing manual involvement in day-to-day IT management. This model is anchored in Kyndryl’s Dual Model IT Ops framework, which focuses on addressing the root cause of problems, rather than reacting to surface-level symptoms. The approach is expected to reduce manual tasks by around 60% by automating routine processes and enabling systems to self-correct.
A key part of the initiative is a unified operations dashboard — a single-pane view that offers real-time insights into service performance, system health, compliance status, and risk exposure. This will help Dr. Reddy’s IT teams stay ahead of issues, make informed decisions quickly, and ensure regulatory requirements are consistently met across geographies.
For a company operating in a highly regulated and fast-moving industry like pharma, the ability to detect and resolve IT issues quickly isn’t just about efficiency — it directly impacts compliance, product delivery timelines, and overall business agility. The partnership with Kyndryl supports Dr. Reddy’s broader push to modernize operations and enable a more resilient, responsive IT backbone as it scales.
